These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 11062371

  • 21. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 22. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 23. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
    Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ.
    J Urol; 2003 Mar 01; 169(3):969-73. PubMed ID: 12576824
    [Abstract] [Full Text] [Related]

  • 24. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.
    D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH.
    J Urol; 2003 Apr 01; 169(4):1320-4. PubMed ID: 12629352
    [Abstract] [Full Text] [Related]

  • 25. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR.
    J Urol; 2001 Oct 01; 166(4):1322-7. PubMed ID: 11547066
    [Abstract] [Full Text] [Related]

  • 26. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.
    J Urol; 2003 Nov 01; 170(5):1860-3. PubMed ID: 14532793
    [Abstract] [Full Text] [Related]

  • 27. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP, Cullen J, Auge BK, L'Esperance JO, Kang SK.
    Cancer; 2007 Sep 01; 110(5):1003-9. PubMed ID: 17614338
    [Abstract] [Full Text] [Related]

  • 28. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
    Graefen M, Walz J, Chun KH, Schlomm T, Haese A, Huland H.
    Eur Urol; 2005 Jun 01; 47(6):756-60. PubMed ID: 15925069
    [Abstract] [Full Text] [Related]

  • 29. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
    Reese AC, Cooperberg MR, Carroll PR.
    J Urol; 2010 Jul 01; 184(1):114-9. PubMed ID: 20478578
    [Abstract] [Full Text] [Related]

  • 30. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct 01; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):795-9. PubMed ID: 15925452
    [Abstract] [Full Text] [Related]

  • 33. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.
    D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, Rhude M, Rocha S, Wein A, Richie JP.
    J Urol; 2001 Dec 01; 166(6):2185-8. PubMed ID: 11696732
    [Abstract] [Full Text] [Related]

  • 34. Outcome based staging for clinically localized adenocarcinoma of the prostate.
    D'Amico AV, Whittington R, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A.
    J Urol; 1997 Oct 01; 158(4):1422-6. PubMed ID: 9302135
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.
    Cancer; 2003 Apr 15; 97(8):1884-93. PubMed ID: 12673714
    [Abstract] [Full Text] [Related]

  • 38. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
    González-San Segundo C, Herranz-Amo F, Alvarez-González A, Cuesta-Álvaro P, Gómez-Espi M, Paños-Fagundo E, Santos-Miranda JA.
    Ann Surg Oncol; 2011 Oct 15; 18(10):2980-7. PubMed ID: 21431406
    [Abstract] [Full Text] [Related]

  • 39. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
    Urology; 2004 Oct 15; 64(4):760-4. PubMed ID: 15491716
    [Abstract] [Full Text] [Related]

  • 40. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer.
    Nguyen PL, Whittington R, Koo S, Schultz D, Cote KB, Loffredo M, Tempany CM, Titelbaum DS, Schnall MD, Renshaw AA, Tomaszewski JE, D'Amico AV.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):400-5. PubMed ID: 15145155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.